Arkolith/Insider Trading/LEXX/Form 4

Carle Vanessa

SecretaryLexaria Bioscience Corp. (LEXX) · full profile →Form 4 · filed Aug 1, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10K
Net Open-Market Flow
-$10K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 31, 2024Sell(S)3K$4.00$10K0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001855763-24-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML